Back to the search results

Park-Klinik Weißensee

Park-Klinik Weißensee
Park-Klinik Weißensee

Schönstraße 80
13086 Berlin

Phone: 030-9628-0
Fax: 030-9628-4005
Mail: ed.nekinilkkrap@eesnessiew-liam

https://www.parkkliniken-weissensee.de/
  • Number of beds: 350
  • Number of specialist departments: 12
  • Number of inpatient cases: 12.619
  • Number of partial inpatient cases: 266
  • Number of outpatient cases: 18.615
  • Hospital owners: Park-Klinik Weißensee GmbH
  • Type of provider: privat
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Quantity performed 153
Exception? No exception
Quantity performed 20
Exception? No exception
Quantity performed 1
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 153
Quantity forecast year: 176
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 20
Quantity forecast year: 20
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 1
Quantity forecast year: 1
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 203
Quantity forecast year: 107
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: no
Number Group
88 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
48 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
33 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission
  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Dozenturen/Lehrbeauftragungen an folgenden Hochschulen und Universitäten: Albert-Ludwigs-Universität Freiburg, Charité - Universitätsmedizin Berlin

Explanation

Studierende im Praktischen Jahr sowie während der Famulatur

Explanation

Studie zum Einfluss der Synovialitis auf das Outcome bei Knie-Artrhoskopien in Kooperation mit dem Universitätsklinikum Freiburg (AGA-Förderung)

Explanation

VIKEP-Studie in Kooperation mit B.Braun unter Leitung des Universitätsklinikums Rostock

Explanation

Explanation

Explanation

Abgeschlossene und laufenden Promotionen.

Training in other healing professions
Comment

Comment

Comment

Comment

Comment

Comment

Comment

Werner Zingler

Patientenfürsprecher

Schönstraße 80
13086 Berlin

Phone: 030 -9628-4158
Mail: ed.leunammi@relgniz.w

B.Sc. Enrico Bock

Qualitätsmanagementbeauftragter-Klinik

Schönstraße 80
13086 Berlin

Phone: 030 -9628-3393
Mail: moc.kinilk-krap@kcob.ocirne

B.Sc. Enrico Bock

Qualitätsmanagementbeauftragter-Klinik

Schönstraße 80
13086 Berlin

Phone: 030 -9628-3393
Mail: moc.kinilk-krap@kcob.ocirne

Prof. Dr. med. Dr. h.c. Hans Behrbohm

Ärztlicher Direktor/Chefarzt Abteilung HNO

Schönstraße 80
13086 Berlin

Phone: 030 -9628-3852
Mail: moc.kinilk-krap@mhobrheb

Prof. Dr. med. Dr. h.c. Hans Behrbohm

Ärztlicher Direktor/Chefarzt der Abteilung HNO und Plastische Operationen

Schönstraße 80
13086 Berlin

Phone: 030 -9628-3850
Mail: moc.kinilk-krap@mhobrheb

Antje Quiring

Schwerbehindertenvertretung

Schönstraße 80
13086 Berlin

Phone: 030 -9628-4494
Mail: moc.kinilk-krap@gniriuq

Schönstraße 80
13086 Berlin

Phone: 030-9628-0
Fax: 030-9628-4005
Mail: ed.nekinilkkrap@eesnessiew-liam

Manon Falk

Pflegedirektorin

Schönstraße 80
13086 Berlin

Phone: 030 -9628-3002
Mail: moc.kinilk-krap@klaf

Petra Klückmann

Kaufmännische Direktorin

Schönstraße 80
13086 Berlin

Phone: 030 -9628-4002
Mail: moc.kinilk-krap@nnamkceulk

Dr. med. Britta Brien

Leiterin Klinikmanagement

Schönstraße 80
13086 Berlin

Phone: 030 -9628-4002
Mail: moc.kinilk-krap@neirb

Inka Dobberphul

Kaufmännische Direktorin

Schönstraße 80
13086 Berlin

Phone: 030 -9628-4004
Mail: ed.nekinilkkrap@luhprebbod.akni

Dipl.-Kfm. Mario Krabbe

Geschäftsführer

Schönstraße 80
13086 Berlin

Phone: 030 -9628-4002
Mail: moc.kinilk-krap@ebbark

Prof. Dr. med. Dr. h.c. Hans Behrbohm

Ärztlicher Direktor/Chefarzt der Abteilung HNO und Plastische Operationen

Schönstraße 80
13086 Berlin

Phone: 030 -9628-3852
Mail: moc.kinilk-krap@mhobrheb

Prof. Dr. med. Marina Backhaus

Stellv. Ärztliche Direktorin/Chefärztin der Abteilung Rheumatologie

Schönstraße 80
13086 Berlin

Phone: 030 -9628-3422
Mail: moc.kinilk-krap@suahkcab

No

IK: 261101721

Location number: 773227000

Old location number: 773227000

Brustkrebszentrum der Park-Klinik Weißensee

Brustkrebszentrum der Park-Klinik Weißensee

Certified until: 03.2022

Darmkrebszentrum Park-Klinik Weißensee Berlin

Darmkrebszentrum Park-Klinik Weißensee Berlin

Certified until: 07.2021

EndoProtheticZentrum der Maximalversorgung Park-Klinik Weißensee

EndoProtheticZentrum der Maximalversorgung Park-Klinik Weißensee

Certified until: 05.2021

Hospital portrait for download Download quality report